Pictet Asset Management (Switzerland)’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-14,669
Closed -$133K 2038
2023
Q1
$133K Buy
+14,669
New +$128K ﹤0.01% 1820
2021
Q4
Sell
-1,767,508
Closed -$51.3M 1814
2021
Q3
$51.3M Buy
+1,767,508
New +$58.8M 0.06% 337

Other funds holding ZYME

Pictet Asset Management (Switzerland)'s ZYME Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) sold out of Zymeworks (ZYME) in Q2 2023, closing a stake of 14,669 shares — an estimated $133K sold.

Pictet Asset Management (Switzerland) first reported a position in ZYME in Q3 2021 and held it in 2 quarters. The position peaked at $51.3M in Q3 2021. 137 funds tracked by Wall St. Rank hold ZYME as of Q2 2023.

  • Pictet Asset Management (Switzerland) reported no remaining Zymeworks position as of Q2 2023 after selling out during the quarter.
  • Pictet Asset Management (Switzerland) sold 14,669 Zymeworks shares in Q2 2023, an estimated $133K.
  • Pictet Asset Management (Switzerland) first reported a position in Zymeworks in Q3 2021 and held it in 2 quarters.
  • Pictet Asset Management (Switzerland)'s Zymeworks position peaked at $51.3M in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Zymeworks as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.